These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23247457)

  • 21. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
    Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
    Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.
    Yang T; Qiu H; Bao W; Li B; Lu C; Du G; Luo X; Wang L; Wan X
    PLoS One; 2013; 8(6):e67458. PubMed ID: 23840707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [E-cadherin promoter methylation and demethylation in epithelial ovarian carcinoma cells].
    Qu PP; Shi Z; Li N
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):538-41. PubMed ID: 19957556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between RAR-beta gene expression defect and its methylation].
    Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [5-aza-2'-deoxycytidine induces changes of histone H3-lysine 9 methylation in bladder tumor cells].
    Yang N; Li Z
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2295-8. PubMed ID: 19087683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
    Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
    Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.
    Hevir-Kene N; Rižner TL
    Chem Biol Interact; 2015 Jun; 234():309-19. PubMed ID: 25437045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The Study of Decitabine Effect on the Endometrial Carcinoma Xenografted in Nude Mice.].
    Li RH; Wang XP; Liu H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):843-847. PubMed ID: 28598109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
    Zhang G; Li XP; Wang JL; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation].
    Sun PM; Wei LH; Gao M; Wang JL; Zhao LJ; Wang DP; Zhang JX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):408-11. PubMed ID: 17697604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Aza-CdR can reverse gefitinib resistance caused by DAPK gene promoter methylation in lung adenocarcinoma cells.
    Yang B; Yang ZG; Gao B; Shao GG; Li GH
    Int J Clin Exp Pathol; 2015; 8(10):12961-6. PubMed ID: 26722491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [5-aza-2'-deoxycytidine suppresses the growth of human lung adenocarcinoma cells in nude mouse xenograft models and its effect on methylation status and expression of TFPI-2 gene].
    Liang J; Yin G; Dong Y; Ma Z; Xiao Y; Ji T
    Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):485-9. PubMed ID: 26463322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
    Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
    Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
    Bender CM; Pao MM; Jones PA
    Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells.
    Bai T; Tanaka T; Yukawa K; Umesaki N
    Int J Oncol; 2006 Feb; 28(2):497-508. PubMed ID: 16391806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness.
    Sato N; Maehara N; Su GH; Goggins M
    J Natl Cancer Inst; 2003 Feb; 95(4):327-30. PubMed ID: 12591989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [5-Aza-CdR regulates the expression of RASSF1A gene in human gastric cancer cell line and inhibits the growth of cells].
    Shen WJ; Dai DQ; Teng Y; Liu HB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):57-60. PubMed ID: 19145506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Growth and gene expression of leukemia cell after treated with methylation inhibitor 5-aza-2'-deoxycytidine].
    Qiao SK; Xu SR; Guo XN
    Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):486-90. PubMed ID: 15555266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [5-aza-2'-deoxycytidine-induced inhibition of CDH13 expression and its inhibitory effect on methylation status in human colon cancer cells in vitro and on growth of xenograft in nude mice].
    Ren JZ; Huo JR
    Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):6-10. PubMed ID: 22490847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Aza-2-deoxycytidine Enhances the Sensitivity of 5-Fluorouracil by Demethylation of the Thymidine Phosphorylase Promoter.
    Nishizawa Y; Ikeda R; Yamamoto M; Kawahara K; Shinsato Y; Minami K; Nitta M; Terazono H; Akiyama SI; Furukawa T; Takeda Y
    Anticancer Res; 2019 Aug; 39(8):4129-4136. PubMed ID: 31366497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.